| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 320 |
| 1 | PREDNISONE | 214 |
| 2 | METHOTREXATE SODIUM | 180 |
| 3 | ACETAMINOPHEN | 174 |
| 4 | METHOTREXATE | 169 |
| 5 | TOCILIZUMAB | 140 |
| 6 | ERGOCALCIFEROL | 123 |
| 7 | DIPHENHYDRAMINE HYDROCHLORIDE | 117 |
| 8 | ACETAMINOPHEN 500MG | 107 |
| 9 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 107 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CHLORINE | 1 | 0.0159 |
| 1 | L-PHENYLALANINE | 1 | 0.0127 |
| 2 | COLLOIDAL SILVER | 1 | 0.0116 |
| 3 | KIT FOR THE PREPARATION OF TECHNETIUM TC99M SESTAMIBI | 1 | 0.0093 |
| 4 | NITROGEN | 1 | 0.0090 |
| 5 | INFLIXIMAB-DYYB | 30 | 0.0087 |
| 6 | SUTIMLIMAB-JOME | 2 | 0.0062 |
| 7 | HYALURONIC ACID | 7 | 0.0060 |
| 8 | BEVACIZUMAB-ADCD | 1 | 0.0049 |
| 9 | HYDROCORTISONE ACETATE AND PRAMOXINE HYDROCHLORIDE | 1 | 0.0047 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 333 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 293 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 193 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 168 |
| 4 | Interleukin-6 Receptor Antagonist [EPC] | 144 |
| 5 | Provitamin D2 Compound [EPC] | 123 |
| 6 | Vitamin C [EPC] | 121 |
| 7 | Kinase Inhibitor [EPC] | 117 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 111 |
| 9 | Vitamin B12 [EPC] | 106 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 7 | 0.0102 |
| 1 | Classical Complement Pathway Inhibitor [EPC] | 2 | 0.0062 |
| 2 | Provitamin D2 Compound [EPC] | 123 | 0.0041 |
| 3 | Interleukin-17 Receptor A Antagonist [EPC] | 5 | 0.0024 |
| 4 | Sclerosing Agent [EPC] | 1 | 0.0022 |
| 5 | Guanylate Cyclase-C Agonist [EPC] | 4 | 0.0019 |
| 6 | Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] | 1 | 0.0017 |
| 7 | Human Immunoglobulin G [EPC] | 32 | 0.0015 |
| 8 | CD38-directed Cytolytic Antibody [EPC] | 8 | 0.0014 |
| 9 | Adrenocorticotropic Hormone [EPC] | 1 | 0.0011 |